Prognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma

Click to increase image sizeClick to decrease image size AcknowledgementsThe authors thank the patients and their families as well as the nurses, pharmacists, advance practitioners, and other support staff from The Ohio State University James Comprehensive Cancer Center who provided patient care.Disclosure statementA.B, Y.H., R.L., N.D., J.B., S.P., A.S., and S.J. have no relevant conflicts of interest. A.S.K. consults for Abbvie, Bristol-Myers Squibb, and Janssen.